These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 4119609)

  • 1. Hypothyroidism with unusual features following propylthiouracil therapy of Graves' disease.
    Pittman JG; Maloof F
    Am J Med Sci; 1972 Dec; 264(6):499-505. PubMed ID: 4119609
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyroid gland in Graves' disease: victim or culprit?
    Chopra IJ; Solomon DH; Johnson DE; Chopra U
    Metabolism; 1970 Oct; 19(10):760-72. PubMed ID: 5535910
    [No Abstract]   [Full Text] [Related]  

  • 3. Neonatal thyroid function after propylthiouracil therapy for maternal Graves' disease.
    Cheron RG; Kaplan MM; Larsen PR; Selenkow HA; Crigler JF
    N Engl J Med; 1981 Feb; 304(9):525-8. PubMed ID: 6893853
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppressibility of thyroid function despite high levels of long-acting thyroid stimulator.
    Wong ET; Doe RP
    Ann Intern Med; 1972 Jan; 76(1):77-84. PubMed ID: 4112158
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of the E-rosette as a test for remission in Graves' disease treated with antithyroid drugs.
    Farid NR; Munro R; Row VV; Volpé R
    Clin Endocrinol (Oxf); 1974 Jan; 3(1):55-61. PubMed ID: 4407296
    [No Abstract]   [Full Text] [Related]  

  • 6. Neonatal hypothyroidism and goiter in one infant of each of two sets of twins due to maternal therapy with antithyroid drugs.
    Refetoff S; Ochi Y; Selenkow HA; Rosenfield RL
    J Pediatr; 1974 Aug; 85(2):240-4. PubMed ID: 4135477
    [No Abstract]   [Full Text] [Related]  

  • 7. The long-acting thyroid stimulatory: is it of importance in Graves' disease.
    McKenzie JM; Zakarija M; D'Amour P; Joasoo A
    N Z Med J; 1975 Jan; 81(531):18-21. PubMed ID: 165442
    [No Abstract]   [Full Text] [Related]  

  • 8. In utero diagnosis and treatment of fetal goitrous hypothyroidism, caused by maternal use of propylthiouracil.
    Van Loon AJ; Derksen JT; Bos AF; Rouwé CW
    Prenat Diagn; 1995 Jul; 15(7):599-604. PubMed ID: 8532617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory tests for evaluating thyroid therapy.
    Kabadi UM
    Am Fam Physician; 1982 Sep; 26(3):183-8. PubMed ID: 6180620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graves' disease in pregnancy years after hypothyroidism with recurrent passive-transfer neonatal Graves' disease in offspring. Therapeutic considerations.
    Volpé R; Ehrlich R; Steiner G; Row VV
    Am J Med; 1984 Sep; 77(3):572-8. PubMed ID: 6548082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships among immunoglobulin markers in Graves' disease.
    Ozawa Y; Maciel RM; Chopra IJ; Solomon DH; Beall GN
    J Clin Endocrinol Metab; 1979 Mar; 48(3):381-7. PubMed ID: 581874
    [No Abstract]   [Full Text] [Related]  

  • 12. Inappropriate suppression of thyrotropin during medical treatment of Graves disease in childhood.
    Sills IN; Horlick MN; Rapaport R
    J Pediatr; 1992 Aug; 121(2):206-9. PubMed ID: 1640284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of thyroid disorders.
    Becker KL
    Postgrad Med; 1973 Feb; 53(2):60-5. PubMed ID: 4688402
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation between thyroid stimulators and 3,5,3'-triiodothyronine suppressibility in patients during treatment for hyperthyroidism with thionamide drugs: comparison of assays by thyroid-stimulating and thyrotropin-displacing activities.
    Kuzuya N; Chiu SC; Ikeda H; Uchimura H; Ito K; Nagataki S
    J Clin Endocrinol Metab; 1979 Apr; 48(4):706-11. PubMed ID: 581876
    [No Abstract]   [Full Text] [Related]  

  • 15. Abnormalities of hypothalamo-hypophyseal-thyroid axis in patients with Graves' ophthalmopathy.
    Chopra IJ; Chopra U; Orgiazzi J
    J Clin Endocrinol Metab; 1973 Dec; 37(6):955-67. PubMed ID: 4201831
    [No Abstract]   [Full Text] [Related]  

  • 16. Antenatal diagnosis and treatment of fetal hypothyroidism. A report of two cases.
    Bruner JP; Dellinger EH
    Fetal Diagn Ther; 1997; 12(4):200-4. PubMed ID: 9354877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of long-acting thyroid stimulator with serum levels of tri-iodothyronine, thyroxine and thyrotropin in Graves' disease.
    Sawhney RC; Kannan V; Rastogi GK
    J Assoc Physicians India; 1975 Feb; 23(2):111-4. PubMed ID: 1242389
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism.
    Momotani N; Noh JY; Ishikawa N; Ito K
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3633-6. PubMed ID: 9360518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
    Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
    Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
    [No Abstract]   [Full Text] [Related]  

  • 20. The relationship of thyroxine turnover to other parameters of peripheral thyroid function in Graves' disease.
    Clifton-Bligh P; Burke G
    J Lab Clin Med; 1975 Jun; 85(6):922-33. PubMed ID: 48532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.